Skip to main content
Toggle navigation
Home
Icon Legend
Program is subject to change
Space limited - first-come, first-served
--------------------
Medical
PWBD
WFH
WGBD
Psychosocial
Nurses
MSK
Laboratory Sciences
Dental
Interpretation in
FRENCH AND SPANISH
Home
Type here to filter the list
Monday, Apr 22nd
11:30 - 12:30
CEST
MO-FP-01 - Free paper session: Pediatrics, inhibitors, and rare bleeding disorders
Location: N106
Chair:
Rubén Berrueco, MD, PhD
– SJD Barcelona Children's Hospital
Medical
Monday, Apr 22nd
11:30 - 12:30
CEST
MO-MED-01 - Comorbidities & aging
Location: N103-N104
Co-Chair:
Miguel A. Escobar, MD
– University of Texas
Co-Chair:
Anabela Aires, MD (she/her/hers)
– Centro Hospitalar Universitário Lisboa Central
Medical
Monday, Apr 22nd
14:00 - 15:15
CEST
MO-MED-02 - Gene Therapy
Location: N103-N104
Co-Chair:
Johnny Mahlangu, MBBCh, MMed
– University of the Witwatersrand and NHLS
Co-Chair:
Steve Pipe
– Michigan Medicine Hemophilia/Coagulation | C. S. Mott Children's Hospital
Medical
Monday, Apr 22nd
16:00 - 17:00
CEST
MO-MED-03 - Bleeding disorder registries
Location: N103-N104
Co-Chair:
Joseph John Manthanathu, MD, MD, MBA (he/him/his)
– Christian Medical College
Co-Chair:
Rubén Berrueco, MD, PhD
– SJD Barcelona Children's Hospital
Medical
Monday, Apr 22nd
16:00 - 17:00
CEST
MO-MED-04 - Acquired bleeding disorders
Location: N101-N102
Co-Chair:
María Eva Mingot-Castellano (she/her/hers)
– Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Universidad de Sevilla
Co-Chair:
Alessandro Casini, MD
– Faculty of Medicine, Division of Angiology and Hemostasis, University of Geneva
Medical
Monday, Apr 22nd
17:15 - 18:15
CEST
MO-MED-05 - Benefits and risks of novel therapies: Redefining hemophilia goals in the era of new technologies
Location: N103-N104
Co-Chair:
Maria Teresa Alvarez Román, MD, PhD (she/her/hers)
– University Hospital La Paz
Co-Chair:
Cedric Hermans, MD, PhD (he/him/his)
– Cliniques Universitaires Saint-Luc
Medical
Tuesday, Apr 23rd
09:00 - 10:00
CEST
TU-MED-06 - Women and girls with bleeding disorders
Location: N103-N104
Co-Chair:
Inmaculada Soto-Ortega, PhD MD (she/her/hers)
– Hospital Universitario Central de Asturias
Co-Chair:
Paula James, MD, FRCPC (she/her/hers)
– Queen's University
Medical
Tuesday, Apr 23rd
10:15 - 10:45
CEST
TU-PL-MED - PLENARY: Defining success in haemophilia care – Are we doing it right?
Location: N103-N104
Chair:
Kathelijn Fischer, MD, PhD, MSc (she/her/hers)
– University Medical Center Utrecht
Speaker:
Alok Srivastava, MD, FRACP, FRCPA, FRCP
– Christian Medical College
Medical
Tuesday, Apr 23rd
11:30 - 12:30
CEST
TU-FP-05 - Free paper session: Young researchers
Location: N106
Chair:
Steve Pipe
– Michigan Medicine Hemophilia/Coagulation | C. S. Mott Children's Hospital
Medical
Tuesday, Apr 23rd
11:30 - 12:30
CEST
TU-MED-07 - PANEL: Making treatment decisions in a rapidly changing environment
Location: N103-N104
Co-Chair:
Víctor Jiménez-Yuste, PhD, MD (he/him/his)
– La Paz University Hospital
Co-Chair:
Pratima Chowdary, MD (she/her/hers)
– KD Comprehensive Care Haemophilia Centre, Royal Free Hospital
Medical
Tuesday, Apr 23rd
14:00 - 15:15
CEST
TU-FP-06 - Free paper session: Quality of life/Outcome research
Location: N106
Chair:
Santiago Bonanad, MD (he/him/his)
– Hospital Universitari i Politècnic La Fe
Medical
Tuesday, Apr 23rd
14:00 - 15:15
CEST
TU-MED-08 - Rare bleeding disorders: Advances in management
Location: N103-N104
Co-Chair:
Tadashi Matsushita, MDPhD (he/him/his)
– Nagoya University Hospital
Co-Chair:
Tahira Zafar, MBBS, DCP, FRCPath
– Hemophilia Patient Welfare Society RAWALPINDI PAKISTAN
Medical
Tuesday, Apr 23rd
16:00 - 17:00
CEST
TU-LBA-01 - Late breaking session: New tech
Location: N103-N104
Co-Chair:
Glenn Pierce, MD, PhD
– World Federation of Hemophilia
Co-Chair:
Flora Peyvandi, MD, PhD (she/her/hers)
– ISTH
Medical
Tuesday, Apr 23rd
16:00 - 17:00
CEST
TU-MED-09 - Challenges in optimal treatment of children
Location: N101-N102
Co-Chair:
Cristina Catarino (she/her/hers)
– Centro Hospitalar Universitário Lisboa Norte
Co-Chair:
Shannon Meeks, MD, MBA (she/her/hers)
– Emory University and Children's Healthcare of Atlanta
Medical
Tuesday, Apr 23rd
17:15 - 18:15
CEST
TU-MED-10 - Unresolved issues in hemostasis in hemophilia
Location: N103-N104
Co-Chair:
Riitta Lassila, MD, PhD (she/her/hers)
– Comprehensive Cancer Center, Hematology, Coagulation Disorders Unit - University of Helsinki
Co-Chair:
Sophie Susen, MD,PhD (she/her/hers)
– CHU Lille
Medical
Tuesday, Apr 23rd
17:15 - 18:15
CEST
TU-MED-11 - Diagnosis and treatment challenges in lower resource countries
Location: N107-N108
Co-Chair:
Veena Selvaratnam, MBBS, MRCP, FRCPath
– Ampang Hospital
Co-Chair:
Daniela Beatriz Neme, MD (she/her/hers)
– Foundation of Hemophilia, Argentina
Medical
Wednesday, Apr 24th
09:00 - 10:00
CEST
WE-FP-07 - Free paper session: Von Willebrand disease
Location: N106
Chair:
Nathan Connell, MD,MPH (he/him/his)
– Brigham And Women's Hospital - Harvard Medical School
Medical
Wednesday, Apr 24th
09:00 - 10:00
CEST
WE-MED-12 - How much prophylaxis is enough?
Location: N103-N104
Co-Chair:
Emna Gouider, MD
– Aziza Othmana Hospital
Medical
Wednesday, Apr 24th
10:15 - 10:45
CEST
WE-PL-MED - PLENARY: Hemophilia in the era of novel therapies: Where do inhibitors feature in the new landscape?
Location: N103-N104
Chair:
Christoph Königs
– University Hospital Frankfurt, Department of Paediatrics
Medical
Wednesday, Apr 24th
11:30 - 12:30
CEST
WE-MED-13 - Diagnosis and treatment of von Willebrand Disease in 2024 and beyond
Location: N103-N104
Co-Chair:
Michelle Lavin, MB BCh BAO, PhD, FRCPath (she/her/hers)
– National Coagulation Centre, St. James's Hospital
Co-Chair:
Robert F. Sidonio, MD, MSc. (he/him/his)
– Aflac Cancer and Blood Disorders
Medical
Wednesday, Apr 24th
13:30 - 14:45
CEST
WE-MED-14 - Outcomes & outcome measures
Location: N103-N104
Co-Chair:
Santiago Bonanad, MD (he/him/his)
– Hospital Universitari i Politècnic La Fe
Co-Chair:
Alok Srivastava, MD, FRACP, FRCPA, FRCP
– Christian Medical College
Medical
Wednesday, Apr 24th
15:15 - 16:15
CEST
WE-FP-09 - Free paper session: Gene Therapy
Location: N106
Chair:
David Lillicrap, MD
– Queen's University
Medical
Wednesday, Apr 24th
15:15 - 16:15
CEST
WE-LBA-02 - Late breaking session: Clinical trials and novel therapies
Location: N101-N102
Chair:
Margareth C. Ozelo, MD, PhD (she/her/hers)
– Hemocentro UNICAMP, University of Campinas
Medical